The American Society for Nanomedicine (ASNM) is pleased to announce its second annual conference to be held at the Bolger Center in Potomac, Maryland, USA on October 14-16, 2010.
This year, ASNM has worked closely with the HIV/AIDS Research Program at the National Institute of Allergy and Infectious Diseases (NIAID), the result of which is a dovetailed conference with a special focus on exploring the use of nanotechnology to address HIV/AIDS-specific research questions and clinical applications. ASNM, in conjunction with the HIV/AIDS Research Program, will host a workshop in which nanomedicine researchers and HIV/AIDS investigators will share strategies and methods to address their respective challenges. The conference will afford a unique opportunity to catalyze interactions between investigators. We would like to devote an ample amount of time to fostering these relationships, so that researchers from both disciplines can expand and apply their newly-blended strategies and knowledge to advance their own studies. The first half of the conference will focus on this joint effort while the second half will focus primarily on capturing the recent novel developments in the field of nanomedicine broadly.
The conference will feature more than fifty world-renowned speakers, who are among the top researchers and leaders in their fields. In the past year, there have been many exciting developments and new insights into the study and application of both HIV/AIDS research and nanomedicine. ASNM would like to invite all researchers interested in exploring these dynamic disciplines to join this conference, with the ultimate goal of enabling practical solutions and new directions to help address the many challenges in each field. The conference program and registration will be available soon online at: http://www.amsocnanomed.org/
ASNM is a registered non-profit organization. We hope to cultivate an open forum of ideas and collaborative efforts, alongside close cooperation and coordination with our American and international colleagues. The membership base of ASNM is drawn from diverse, yet overlapping fields such as nanotechnology, engineering, medicine, law, policy, ethics, toxicology, biotechnology, pharmaceutical sciences and biomedical sciences. As a member, you will have the opportunity to participate (including being a candidate) in the open elections for the society officers, board members and operating committees, and receive reduced rates to attend ASNM conferences. Please note that membership is not limited to US citizens. For non-members, the conference registration fee includes a one-year membership into the ASNM in addition to conference attendance. For colleagues in the industry, you are invited to join our innovative, dynamic society by signing up your company as a corporate member. We look forward to seeing you at the conference and benefiting from your active participation in the American Society for Nanomedicine.
Esther H. Chang, Ph.D.
Interim President of the American Society for Nanomedicine
Professor of Oncology, Georgetown University Medical Center (Washington, DC)